Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
Condition: Neoadjuvant Therapy of Non-metastatic Locally Advanced Renal Cell Carcinoma Interventions: Drug: Toripalimab; Drug: Axitinib Sponsor: RenJi Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hospitals | Kidney Cancer | Neoadjuvant Therapy | Renal Cell Carcinoma | Research